Evaluation of Recombinant Factor VIII Fc (Eloctate) Activity by Thromboelastometry in a Multicenter Phase 3 Clinical Trial and Correlation With Bleeding Phenotype

Blood Coagulation and Fibrinolysis - United States
doi 10.1097/mbc.0000000000000638
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Evaluation of the Toxicology and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein in Animals

Thrombosis Research
Hematology
2015English

Von Willebrand Factor and Factor VIII Levels After Desmopressin Are Associated With Bleeding Phenotype in Type 1 VWD

Blood advances
Hematology
2019English

Indirect Comparison of the Efficacy of Recombinant Factor Viii Fc Fusion Protein and Other Factor Viii Products for ProphylaxisModeling the Effect of Compliance

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Circumventing Furin Enhances Factor VIII Biological Activity and Ameliorates Bleeding Phenotypes in Hemophilia Models

JCI insight
Medicine
2016English

Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2009English

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

The Double Hazard of Bleeding and Thrombosis in Hemostasis From a Clinical Point of View: A Global Assessment by Rotational Thromboelastometry (ROTEM)

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision

Turkish Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy